🇺🇸 FDA

Intelligence · Clinical Pipeline

BRIGHT MINDS BIOSCIENCES Pipeline

All ClinicalTrials.gov programs at BRIGHT MINDS BIOSCIENCES — phase, modality, and trial IDs.

Programs
1,063

Quick answer

BRIGHT MINDS BIOSCIENCES has 1,063 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. PIO

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    phase 2 small molecule terminated

    1 trial

  2. PPRS

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Use

    phase 2 other completed

    1 trial

  3. Panitumumab

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Head and Neck Squamous Cancer

    phase 2 small molecule completed

    1 trial

  4. Parenting in 2 Worlds (P2W)

    BRIGHT MINDS BIOSCIENCES INC.

    Parenting

    phase 2 other active

    1 trial

  5. Pemoline

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 2 small molecule completed

    2 trials

  6. Pepinemab

    BRIGHT MINDS BIOSCIENCES INC.

    Alzheimer Disease

    phase 2 small molecule completed

    1 trial

  7. Perindopril

    BRIGHT MINDS BIOSCIENCES INC.

    Alzheimer's Disease

    phase 2 small molecule terminated

    1 trial

  8. Pioglitazone

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 2 small molecule completed

    1 trial

  9. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Dependence

    phase 2 small molecule completed

    2 trials

  10. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 2 small molecule active

    1 trial

  11. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Addiction

    phase 2 small molecule completed

    1 trial

  12. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Bipolar Depression

    phase 2 small molecule terminated

    1 trial

  13. Placebo + Inactive Marijuana (0% THC)

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Use

    phase 2 small molecule completed

    1 trial

  14. Placebo capsules

    BRIGHT MINDS BIOSCIENCES INC.

    Pain Threshold

    phase 2 small molecule completed

    1 trial

  15. Placebo session 1, Aprepitant session 2

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    1 trial

  16. Placebos

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis

    phase 2 small molecule completed

    1 trial

  17. Prazosin

    BRIGHT MINDS BIOSCIENCES INC.

    Continuous Methamphetamine Abuse

    phase 2 small molecule completed

    1 trial

  18. Pre-Quit Nicotine Lozenges

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    phase 2 small molecule completed

    1 trial

  19. Progesterone

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 2 small molecule completed

    1 trial

  20. Progesterone

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Use

    phase 2 small molecule completed

    1 trial

  21. Proleukin

    BRIGHT MINDS BIOSCIENCES INC.

    Alzheimer Disease

    phase 2 small molecule active

    1 trial

  22. Propranolol

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 2 small molecule completed

    1 trial

  23. Propranolol

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    2 trials

  24. Psilocybin

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 2 small molecule completed

    1 trial

  25. Psilocybin

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 2 small molecule active

    1 trial

  26. Psilocybin

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 2 small molecule active

    1 trial

  27. PvCS/Montanide ISA-51 VG Vaccine

    BRIGHT MINDS BIOSCIENCES INC.

    Plasmodium Vivax Malaria

    phase 2 mab active

    1 trial

  28. Quetiapine

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Dependence

    phase 2 small molecule completed

    1 trial

  29. QuitAdvisorMD Software Algorithm

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    phase 2 other active

    1 trial

  30. Ramelteon

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 2 small molecule completed

    1 trial

  31. Real cTBS

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 other completed

    1 trial

  32. Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)

    BRIGHT MINDS BIOSCIENCES INC.

    Human Papilloma Virus Infection

    phase 2 mab completed

    1 trial

  33. Recombivax

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis B

    phase 2 mab completed

    1 trial

  34. Recovery Line Support System

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    phase 2 other completed

    1 trial

  35. Recovery by Choice

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    phase 2 other completed

    1 trial

  36. Reserpine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 2 small molecule completed

    1 trial

  37. Residential

    BRIGHT MINDS BIOSCIENCES INC.

    Usual Aftercare

    phase 2 other completed

    1 trial

  38. Rimonabant

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    phase 2 small molecule terminated

    1 trial

  39. Risperidone

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 2 small molecule terminated

    6 trials

  40. Ritanserin

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 2 small molecule completed

    1 trial

  41. Rotigotine Transdermal System [Neupro]

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    phase 2 small molecule active

    1 trial

  42. SD-101 dermal cream (6%)

    BRIGHT MINDS BIOSCIENCES INC.

    Epidermolysis Bullosa

    phase 2 small molecule terminated

    1 trial

  43. SL-BUP

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder (OUD)

    phase 2 small molecule active

    1 trial

  44. Sativex

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Dependence

    phase 2 small molecule completed

    1 trial

  45. Scaling and root planing, and Septilin for 7 days

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Periodontitis

    phase 2 small molecule completed

    1 trial

  46. SelG1

    BRIGHT MINDS BIOSCIENCES INC.

    Sickle Cell Disease

    phase 2 small molecule completed

    1 trial

  47. Selegiline

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 2 small molecule completed

    1 trial

  48. Selegiline

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Cessation

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does BRIGHT MINDS BIOSCIENCES have?

1,063 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.